Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricard Cervera

Showing results (31-40 of 412) with videos related to

Pageof 42
Sort By:
Nature Reviews. Rheumatology|April 14, 2010
Antiphospholipid syndrome: frequency, main causes and risk factors of mortalityGerard Espinosa, Ricard Cervera
European Journal of Internal Medicine|April 10, 2023
Mortality and causes of death in systemic lupus erythematosus revisitedGiuseppe Barilaro, Ricard Cervera
Nature Reviews. Rheumatology|August 8, 2012
Connective tissue diseases: classification criteria for SLE: the latest-but not least-attemptRicard Cervera, Gerard Espinosa
The Israel Medical Association Journal : IMAJ|January 24, 2009
Microangiopathic antiphospholipid antibody-associated syndromes: a tribute to Ronald AshersonRicard Cervera, Yehuda Shoenfeld
European Journal of Internal Medicine|October 2, 2024
Treatment of systemic lupus erythematosus in real lifeGiuseppe Barilaro, Ricard Cervera
The Lancet. Rheumatology|January 26, 2024
Targeting interferon I in SLE: a promising new perspectiveRoberto Ríos-Garcés, Ricard Cervera
European Journal of Internal Medicine|July 4, 2021
Anti Ro52 antibodies: One step further, but still not there yetRoberto Ríos-Garcés, Ricard Cervera
Immunobiology|December 6, 2005
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristicsRicard Cervera, Ronald A Asherson
Clinical Reviews in Allergy & Immunology|October 6, 2007
Pulmonary hypertension, antiphospholipid antibodies, and syndromesRonald A Asherson, Ricard Cervera
Autoimmunity Reviews|July 10, 2003
Anti-chromatin (anti-nucleosome) autoantibodiesRufus W Burlingame, Ricard Cervera
Pageof 42

Showing results (31-40 of 412) with videos related to

Sort By:
Pageof 42
Nature Reviews. Rheumatology|April 14, 2010
Antiphospholipid syndrome: frequency, main causes and risk factors of mortalityGerard Espinosa, Ricard Cervera
European Journal of Internal Medicine|April 10, 2023
Mortality and causes of death in systemic lupus erythematosus revisitedGiuseppe Barilaro, Ricard Cervera
Nature Reviews. Rheumatology|August 8, 2012
Connective tissue diseases: classification criteria for SLE: the latest-but not least-attemptRicard Cervera, Gerard Espinosa
The Israel Medical Association Journal : IMAJ|January 24, 2009
Microangiopathic antiphospholipid antibody-associated syndromes: a tribute to Ronald AshersonRicard Cervera, Yehuda Shoenfeld
European Journal of Internal Medicine|October 2, 2024
Treatment of systemic lupus erythematosus in real lifeGiuseppe Barilaro, Ricard Cervera
The Lancet. Rheumatology|January 26, 2024
Targeting interferon I in SLE: a promising new perspectiveRoberto Ríos-Garcés, Ricard Cervera
European Journal of Internal Medicine|July 4, 2021
Anti Ro52 antibodies: One step further, but still not there yetRoberto Ríos-Garcés, Ricard Cervera
Immunobiology|December 6, 2005
Antiphospholipid syndrome associated with infections: clinical and microbiological characteristicsRicard Cervera, Ronald A Asherson
Clinical Reviews in Allergy & Immunology|October 6, 2007
Pulmonary hypertension, antiphospholipid antibodies, and syndromesRonald A Asherson, Ricard Cervera
Autoimmunity Reviews|July 10, 2003
Anti-chromatin (anti-nucleosome) autoantibodiesRufus W Burlingame, Ricard Cervera
Pageof 42